Signs of Acute and Chronic Pyelonephritis

An Overview of Acute and Chronic Pyelonephritis

Pyelonephritis is an inflammatory condition affecting the human kidneys and upper urinary tract that can manifest in both acute and chronic forms, representing significant challenges for healthcare practitioners. Indeed, left untreated, this condition can result in serious debilitation or even death. To determine the facts about this disorder, the purpose of this paper is to review the relevant peer-reviewed literature concerning the intricate aspects of acute and chronic pyelonephritis, providing a comprehensive overview of the disease’s pathophysiology as well as genetic and genomic influences. In addition, a discussion concerning the clinical presentation, diagnostic approaches, and available treatments currently used for pyelonephritis is followed by a summary of the findings that emerged from the juried literature.

Research on Acute and Chronic Pyelonephritis

Pathophysiology.

Acute and chronic pyelonephritis are both typically caused by an ascending bacterial infection from the lower urinary tract, most commonly by uropathogenic strains of Escherichia coli. For example, according to Choong et al. (2019), “Pyelonephritis represents a subset of urinary tract infections that occur from bacteria ascending from the lower to the upper reaches of the genitourinary system, such as the kidney” (p. 37). The pathogenesis of this disorder begins with the colonization of the periurethral area and subsequent ascension of bacteria through the urethra and bladder, ultimately reaching the kidneys and renal pelvis. The resulting infection causes an inflammatory response in the renal parenchyma and interstitial tissue, leading to the formation of acute suppurative lesions or abscesses within the kidney. This inflammatory process can result in diminished renal blood flow, impaired glomerular filtration, and tubular dysfunction, which can ultimately lead to acute kidney injury and sepsis if left untreated (Choong et al., 2019).

Virulence factors of the infecting bacteria, such as adhesins, toxins, and iron acquisition systems, play a crucial role in their ability to evade host defense mechanisms and establish infection within the kidneys (Kogan, 2021). Likewise, host factors such as anatomical abnormalities, urinary stasis, or compromised immune function can increase the risk and severity of acute pyelonephritis. The pathophysiology of chronic pyelonephritis also involves a complex interplay between bacterial virulence factors, host immune responses, and the development of renal scarring and fibrosis (Grigoriu, 2022).

Genetic and genomic influences.

Genetic and genomic factors play a significant role in the susceptibility and pathogenesis of pyelonephritis. Studies have identified several genetic variations and polymorphisms associated with an increased risk of developing acute and chronic pyelonephritis. These include mutations in genes involved in immune response, such as toll-like receptors (TLRs) and cytokine genes (Aksu et al., 2024). In addition, genetic variations in factors that affect urinary tract anatomy and function can also predispose individuals to recurrent infections and chronic pyelonephritis (Aksu et al., 2024).

Signs and symptoms.

The signs and symptoms of pyelonephritis can vary depending on the acuity and severity of the infection. In acute pyelonephritis, patients typically present with fever, flank pain, chills, nausea and vomiting but patients suffering from chronic pyelonephritis may present with less obvious symptoms such as fatigue and malaise (Ahmed & Arifuddin, 2024).

Diagnostic and lab work.

The diagnosis of pyelonephritis involves a combination of clinical evaluation, laboratory tests, and imaging studies. In this regard, Yamashita et al. (2023) report that, “Accurate diagnosis and early treatment are important. Although there is no consensus on the diagnostic criteria for pyelonephritis, detecting bacteria in urine culture is crucial” (p. 365). Laboratory analyses for pyelonephritis include urinalysis to rule out pyuria, hematuria, and bacteriuria, as well as urine culture to identify the causative organism and guide antibiotic therapy. In addition, blood tests, such as complete blood count and inflammatory markers can also facilitate assessing the severity of the infection and monitoring response to treatment (Yamashita et al., 2023).

Medications and treatments used.

The treatment of pyelonephritis typically involves antibiotics, with the choice of antibiotic guided by local resistance patterns and the severity of the infection. For acute pyelonephritis, empiric broad-spectrum antibiotics, such as fluoroquinolones or third-generation cephalosporins, are often initiated and adjusted based on culture and sensitivity results. In severe cases, intravenous antibiotics may be required initially, followed by a transition to oral therapy after patients improve (Lin et al., 2022). In addition, in severe cases, surgery may be required to remove obstructions or drain abscesses and subsequent supportive care, including adequate hydration, pain management, and management of underlying comorbidities, is also essential for the treatment of both acute and chronic pyelonephritis (Yoo et al., 2021).

Conclusion

The research showed that both acute and chronic pyelonephritis represent a significant health concern that requires prompt and appropriate management. the complex pathophysiology of the condition, influenced by bacterial virulence factors, host immune responses, and anatomical abnormalities. Furthermore, the role of genetic and genomic influences in predisposing individuals to pyelonephritis has been intensively studied, paving the way for personalized risk assessment and targeted interventions. While the clinical presentation can vary, recognizing the signs and symptoms is crucial for early diagnosis and treatment initiation. Accurate diagnosis relies on a combination of clinical evaluation, laboratory testing, and imaging modalities, each contributing to a comprehensive assessment of the condition’s severity and extent. Finally, the research also showed that the treatment of pyelonephritis typically involves antimicrobial therapy, with the choice of antibiotics guided by local resistance patterns and the severity of the infection. In some cases, surgical interventions or supportive care may also be necessary to manage complications and underlying comorbidities.

References

Ahmed, S. F., & Arifuddin, M. K. (2024). A Comprehensive Analysis of Clinical Characteristics, Microbial Profile, Prognostic Indicators, and Treatment in Patients with Type 2 Diabetes Mellitus and Acute Pyelonephritis. Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 15(1), 496–505.